Getinge AB (MIL:1GETI) Other Current Receivables: €163 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1GETI Getinge AB MIL:1GETI
53 GF Score
Price €17.10
GF Value €17.70
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Getinge AB Other Current Receivables?

Getinge AB MIL:1GETI 53 Other Current Receivables is €163 Mil as of Jun. 2026. GuruFocus rates MIL:1GETI with a GF Score™ of 53/100 and a GF Value™ of €17.70 (Fairly Valued). The stock has 10 warning signs investors should review.

Getinge AB's Other Current Receivables for the quarter that ended in Jun. 2026 was €163 Mil.

Getinge AB's quarterly Other Current Receivables increased from Dec. 2025 (€157.50 Mil) to Mar. 2026 (€177.14 Mil) but then stayed the same from Mar. 2026 (€177.14 Mil) to Jun. 2026 (€163.37 Mil).

Getinge AB's annual Other Current Receivables increased from Dec. 2023 (€118.63 Mil) to Dec. 2024 (€165.44 Mil) but then declined from Dec. 2024 (€165.44 Mil) to Dec. 2025 (€157.50 Mil).

Getinge AB Other Current Receivables Related Terms

Getinge AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Getinge AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Getinge AB Other Current Receivables Chart

Getinge AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 124.43 144.99 118.63 165.44 157.50

Getinge AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 200.67 194.71 157.50 177.14 163.37
MIL:1GETI
53GF Score
Getinge AB MIL:1GETI
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Getinge AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €163 Mil mean?
Getinge AB (MIL:1GETI) has a Other Current Receivables of €163 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Getinge AB and its competitors.
Is Getinge AB's Other Current Receivables too high?
Getinge AB's current Other Current Receivables is €163 Mil. Overall, Getinge AB has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Getinge AB's Other Current Receivables compare to ABT and SYK?
Getinge AB's Other Current Receivables of €163 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Getinge AB and its competitors. Getinge AB's current Other Current Receivables is €163 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getinge AB stock overvalued right now?
Based on GuruFocus' analysis, Getinge AB (MIL:1GETI) is currently considered Fairly Valued. The stock's GF Value™ is €17.70, compared to a current price of €17.10 — trading 3.4% below its estimated fair value. The current Other Current Receivables is €163 Mil. Getinge AB's overall GF Score™ is 53/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Getinge AB (MIL:1GETI), the current Other Current Receivables is €163 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Getinge AB (MIL:1GETI) Overvalued in 2026?

Based on GuruFocus' analysis, Getinge AB stock appears to be undervalued. The current stock price of €17.10 is trading 3.4% below its estimated GF Value™ of €17.70. GuruFocus considers Getinge AB to be Fairly Valued.

Key valuation signals for MIL:1GETI:

  • Other Current Receivables: €163 Mil
  • GF Value™: €17.70 vs. price of €17.10 (3.4% below fair value)
  • GF Score™: 53/100 with 10 warning signs

No single metric tells the full story. See the MIL:1GETI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Getinge AB Business Description

Address Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, 417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
53GF Score

Get the complete analysis for MIL:1GETI

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.10
Price
€17.70
GF Value